Hepatic Artery Infusion Chemotherapy Combined with Camrelizumab plus Rivoceranib for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Multicenter Propensity Score Matching Analysis
Research Square (Research Square)